| 1. | Tamoxifen approved by fda for marketing as a treatment drug
Fda批准他末昔芬作为治疗药物进入市场 |
| 2. | Progress of research of the mechanism of tamoxifen resistance in breast cancer
乳腺癌三苯氧胺耐药机制的研究进展 |
| 3. | Reversal of multidrug resistance in leukemia cell line by cyclosporin a combining with tamoxifen and interferon
02细胞多药耐药机制的研究 |
| 4. | 7 this observation has not been confirmed by other trials employing long term tamoxifen treatment
这个观察结果还未被其他使用他莫西酚进行治疗的实验所证实。 |
| 5. | Anti - estrogen drugs such as tamoxifen ( noaldex ) are a standard treatment for hormone - dependent breast cancer
抗雌激素* *物如他莫昔酚是激素依赖性乳癌的标准治疗。 |
| 6. | Anti - estrogen drugs such as tamoxifen ( novaldex ) are a standard treatment for hormone - dependent breast cancer
抗雌激素药物如他莫昔酚是激素依赖性乳癌的标准治疗。 |
| 7. | However , tamoxifen is associated with increased risk of death from other causes , such as strokes and endometrial cancer
但是三苯氧胺可以增加其他原因的死亡率，例如休克和子宫内膜癌等。 |
| 8. | Women who had used antidepressants in the year before starting tamoxifen were also more likely to quit ( hr 1 . 41 )
在开始使用他莫西芬前一年内使用过抗抑郁药的妇女也容易停药（风险比1 . 41 ） 。 |
| 9. | Tamoxifen was the first estrogen modulator shown to increase survival and reduce the risk of breast cancer recurrence
三苯氧胺是第一个雌激素调节剂，可增加患者的生存率和降低乳腺癌复发的危险。 |
| 10. | Despite this risk , tamoxifen and another drug in this class , raloxifene , remain an extensively used and popular treatment
虽然存在这些副作用，三苯氧胺和另一种同类药物雷洛西芬已经被广泛用于乳腺癌的治疗。 |
